NEW
YORK, June 8, 2021 /PRNewswire-PRWeb/ -- Mount
Sinai Health System has recruited an internationally recognized
expert in the management of breast cancer and HIV-associated
malignancies, Joseph A. Sparano, MD,
FACP, as Chief of Hematology and Medical Oncology and Deputy
Director of The Tisch Cancer Institute (TCI). Dr. Sparano will also
hold the Ezra M. Greenspan, MD Professorship in Clinical Cancer
Therapeutics at the Icahn School of Medicine at Mount Sinai and will oversee the expansion of
clinical and research capacities of the Division and TCI.
"Dr. Sparano brings a wealth of experience in clinical,
research, and educational excellence," said Ramon Parsons, MD, PhD, Director of The Tisch
Cancer Institute, Chair of Oncological Sciences, and Ward-Coleman
Chair in Cancer Research at Icahn Mount Sinai. "He will be
instrumental in expanding Mount
Sinai's footprint in cancer advancements, fostering our
mission of providing superior cancer care with special attention to
equity, and guiding the institution's progress toward National
Cancer Institute (NCI) Comprehensive Cancer Center status, the
highest designation granted to a cancer center by the NCI."
Dr. Sparano will maintain an active clinical practice at
Mount Sinai. He joins TCI
following a distinguished 33-year career at the Albert Einstein
College of Medicine and Montefiore Medical Center, where he was
Professor of Medicine, and Obstetrics, Gynecology and Women's
Health; Associate Chairman for Clinical Research in the Department
of Oncology; and Associate Director for Clinical Research at the
Albert Einstein Cancer Center. He served as Chief of the Section of
Breast Medical Oncology since 1995 and Associate Chairman of
Medical Oncology since 2001.
Dr. Sparano led a breakthrough clinical trial in breast cancer
research, the Trial Assigning Individualized Options for Treatment
(Rx), known as TAILORx—the first and largest NCI precision medicine
trial. The trial led to changes in treatment guidelines from both
the American Society of Clinical Oncology and the National
Comprehensive Cancer Network. TAILORx results were published in The
New England Journal of Medicine in 2015, 2018, and 2019.
Dr. Sparano has also conducted impactful studies aimed at
improving the outcomes of HIV‐positive patients with cancer,
including research on novel approaches for treating non‐Hodgkin
lymphoma and anal cancer in individuals with HIV. He has also
focused his research on improving racial disparities in cancer care
and on cancer metastasis.
Dr. Sparano is Chair and Principal Investigator of the AIDS
Malignancy Consortium, serves as Deputy Chair of the Eastern
Cooperative Oncology Group (ECOG)-American College of Radiology
Imaging Network (ACRIN) Cancer Research Group, and is a member of
the Board of Managers of the PreECOG Research Foundation and the
Early Breast Cancer Trialists' Collaborative Group Steering
Committee.
Dr. Sparano has received some of the most prestigious awards in
the field of medical oncology, including the ECOG Young
Investigator Award, the Charles
Moertel Award and Lecture by the Alliance for Cancer
Clinical Trials, the American Association for Cancer Research
William L. McGuire Award and
Lecture, and the American Society of Clinical Oncology Gianni
Bonadonna Award and Lecture.
He is a graduate of the Sophie Davis School of Biomedical
Education at the City College of New
York, a program that included education at Mount Sinai and New York
Medical College. He completed internship and residency
training in Internal Medicine at St. Vincent's Hospital and Medical
Center of New York and a
fellowship in Medical Oncology at Albert Einstein Cancer Center and
Montefiore Medical Center.
About the Mount Sinai Health System
The Mount Sinai Health System is New
York City's largest academic medical system, encompassing
eight hospitals, a leading medical school, and a vast network of
ambulatory practices throughout the greater New York region. Mount Sinai is a national and international
source of unrivaled education, translational research and
discovery, and collaborative clinical leadership ensuring that we
deliver the highest quality care—from prevention to treatment of
the most serious and complex human diseases. The Health System
includes more than 7,200 physicians and features a robust and
continually expanding network of multispecialty services, including
more than 400 ambulatory practice locations throughout the five
boroughs of New York City,
Westchester, and Long Island. The Mount Sinai Hospital is
ranked No. 14 on U.S. News & World Report's "Honor Roll" of the
Top 20 Best Hospitals in the country and the Icahn School of
Medicine as one of the Top 20 Best Medical Schools in country.
Mount Sinai Health System hospitals are consistently ranked
regionally by specialty and our physicians in the top 1% of all
physicians nationally by U.S. News & World Report.
For more information, visit https://www.mountsinai.org or find
Mount Sinai on Facebook, Twitter
and YouTube.
Media Contact
Marlene Naanes, Mount Sinai
Health System, 212-241-9200, marlene.naanes@mountsinai.org
Twitter
SOURCE Mount Sinai Health System